| Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study TM Maher, S Stowasser, Y Nishioka, ES White, V Cottin, I Noth, M Selman, ... The Lancet respiratory medicine 7 (9), 771-779, 2019 | 79 | 2019 |
| Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy Y Zaizen, K Azuma, S Kurata, E Sadashima, S Hattori, T Sasada, ... European journal of radiology 81 (12), 4179-4184, 2012 | 73 | 2012 |
| Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe, S Hattori, ... Medical oncology 30, 1-7, 2013 | 52 | 2013 |
| Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia T Kinoshita, K Azuma, T Sasada, M Okamoto, S Hattori, Y Imamura, ... Oncology letters 4 (3), 477-482, 2012 | 52 | 2012 |
| Elevation of pulmonary CD163+ and CD204+ macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients T Nouno, M Okamoto, K Ohnishi, S Kaieda, M Tominaga, Y Zaizen, ... Journal of thoracic disease 11 (9), 4005, 2019 | 51 | 2019 |
| Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with … S Sakamoto, M Okamoto, S Kaieda, K Fujimoto, S Nagata, M Tominaga, ... Respiratory investigation 56 (6), 464-472, 2018 | 38 | 2018 |
| Prognostic value of EGFR mutation and ERCC1 in patients with non-small cell lung cancer undergoing platinum-based chemotherapy F Yamashita, K Azuma, T Yoshida, K Yamada, A Kawahara, S Hattori, ... PloS one 8 (8), e71356, 2013 | 31 | 2013 |
| A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world M Nakamura, M Okamoto, K Fujimoto, T Ebata, M Tominaga, T Nouno, ... Annals of translational medicine 7 (12), 2019 | 24 | 2019 |
| Deep-learning-aided detection of mycobacteria in pathology specimens increases the sensitivity in early diagnosis of pulmonary tuberculosis compared with bacteriology tests Y Zaizen, Y Kanahori, S Ishijima, Y Kitamura, HS Yoon, M Ozasa, ... Diagnostics 12 (3), 709, 2022 | 19 | 2022 |
| Dental technicians' pneumoconiosis M Okamoto, M Tominaga, S Shimizu, C Yano, K Masuda, M Nakamura, ... Internal Medicine 56 (24), 3323-3326, 2017 | 19 | 2017 |
| Concordance between sequential transbronchial lung cryobiopsy and surgical lung biopsy in patients with diffuse interstitial lung disease Y Zaizen, Y Kohashi, K Kuroda, K Tabata, Y Kitamura, A Hebisawa, ... Diagnostic Pathology 14, 1-7, 2019 | 17 | 2019 |
| Comparison of nuclear grade, necrosis, and histologic subtype between biopsy and resection in pleural malignant mesothelioma: an international multi-institutional analysis JJ Schulte, DB Chapel, R Attanoos, L Brcic, J Burn, KJ Butnor, N Chang, ... American journal of clinical pathology 156 (6), 989-999, 2021 | 15 | 2021 |
| Clinical practice in management of hydration for lung cancer patients receiving cisplatin-based chemotherapy in Japan: a questionnaire survey K Yamada, T Yoshida, Y Zaizen, Y Okayama, Y Naito, F Yamashita, ... Japanese Journal of Clinical Oncology 41 (11), 1308-1311, 2011 | 15 | 2011 |
| Early intervention of pulmonary rehabilitation for fibrotic interstitial lung disease is a favorable factor for short-term improvement in health-related quality of life S Matsuo, M Okamoto, T Ikeuchi, Y Zaizen, A Inomoto, R Haraguchi, ... Journal of Clinical Medicine 10 (14), 3153, 2021 | 13 | 2021 |
| Pathology of idiopathic interstitial pneumonias Y Zaizen, J Fukuoka Surgical pathology clinics 13 (1), 91-118, 2020 | 13 | 2020 |
| Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell … ZP Oo, A Bychkov, Y Zaizen, M Yamasue, J Kadota, J Fukuoka Respiratory medicine case reports 26, 244-247, 2019 | 9 | 2019 |
| Analysis of early biomarkers associated with the development of critical respiratory failure in coronavirus disease 2019 (COVID-19) H Yamada, M Okamoto, Y Nagasaki, S Yoshio, T Nouno, C Yano, ... Diagnostics 12 (2), 339, 2022 | 8 | 2022 |
| Pneumoconiosis with a sarcoid-like reaction other than beryllium exposure: a case report and literature review F Hayashi, T Kido, N Sakamoto, Y Zaizen, M Ozasa, M Yokoyama, H Yura, ... Medicina 56 (11), 630, 2020 | 8 | 2020 |
| Phase I study of carboplatin combined with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer H Takeoka, K Yamada, K Azuma, Y Zaizen, F Yamashita, T Yoshida, ... Japanese Journal of Clinical Oncology 44 (5), 472-478, 2014 | 8 | 2014 |
| Enhanced immune complex formation in the lungs of patients with dermatomyositis Y Zaizen, M Okamoto, K Azuma, J Fukuoka, H Hozumi, N Sakamoto, ... Respiratory Research 24 (1), 86, 2023 | 7 | 2023 |
Prof. Junya Fukuoka, MD. PhD.Dept of Pathology Informatics, Nagasaki University / Dept of Pathology, Kameda Medical Center在 nagasaki-u.ac.jp 的电子邮件经过验证
